Tower Research Capital (TRC)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $868K | Buy |
|
|||||
|
2025
Q2 | $119K | Sell |
|
|||||
|
2025
Q1 | $574K | Buy |
|
|||||
|
2024
Q4 | $19.8K | Sell |
|
|||||
|
2024
Q3 | $1.02M | Sell |
|
|||||
|
2024
Q2 | $1.12M | Buy |
|
|||||
|
2024
Q1 | $395K | Buy |
|
|||||
|
2023
Q4 | $141K | Buy |
|
|||||
|
2023
Q3 | $26K | Sell |
|
|||||
|
2023
Q2 | $75.2K | Buy |
|
|||||
|
2023
Q1 | $46K | Sell |
|
|||||
|
2022
Q4 | $105K | Sell |
|
|||||
|
2022
Q3 | $573K | Buy |
|
|||||
|
2022
Q2 | $204K | Buy |
|
|||||
|
2022
Q1 | $0 | Sell |
|
|||||
|
2021
Q4 | $128K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $305K | Sell |
|
|||||
|
2021
Q1 | $295K | Sell |
|
|||||
|
2020
Q4 | $793K | Buy |
|
|||||
|
2020
Q3 | $64K | Buy |
|
|||||
|
2020
Q2 | $10K | Sell |
|
|||||
|
2020
Q1 | $487K | Buy |
|
|||||
|
2019
Q4 | $13K | Sell |
|
|||||
|
2019
Q3 | $238K | Buy |
|
|||||
|
2019
Q2 | $58K | Sell |
|
|||||
|
2019
Q1 | $437K | Buy |
|
|||||
|
2018
Q4 | $4K | Sell |
|
|||||
|
2018
Q3 | $119K | Sell |
|
|||||
|
2018
Q2 | $138K | Sell |
|
|||||
|
2018
Q1 | $956K | Buy |
|
|||||
|
2017
Q4 | $7K | Buy |
|
|||||
|
2017
Q3 | $4K | Sell |
|
|||||
|
2017
Q2 | $25K | Sell |
|
|||||
|
2017
Q1 | $65K | Buy |
|
|||||
|
2016
Q4 | $1K | Sell |
|
|||||
|
2016
Q3 | $114K | Buy |
|
|||||
|
2016
Q2 | $84K | Buy |
|
|||||
|
2016
Q1 | $14K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $29K | Buy |
|
|||||
|
2015
Q2 | $7K | Buy |
|
|||||
|
2015
Q1 | $0 | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $22K | Buy |
|
|||||
|
2014
Q2 | $11K | Sell |
|
|||||
|
2014
Q1 | $238K | Buy |
|
|||||
|
2013
Q4 | $65K | Sell |
|
|||||
|
2013
Q3 | $70K | Buy |
|
|||||
|
2013
Q2 | $28K | Buy |
|